Astellas Pharma (ALPMY) Stock Price, Quote, News & History

Astellas Pharma Inc (ALPMY) Stock Price, Quote, News & History

ALPMYOTCPK

Trade with Public

$14.77

-0.68-4.40%

At close: Mar 12, 5:00 PM EST

Key Statistics

Open

$14.77

Volume / Avg.

0 / 140.87K

Day Range

- - -

52 Wk Range

8.37 - 16.95

Market Cap

$26.46B

P/E Ratio

33.81

Dividend Yield

3.44%

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Astellas Pharma Inc News

These Analysts Boost Their Forecasts On Vir Biotechnology

Avi Kapoor

What's Going On With Kyntra Bio Stock Tuesday?

Kyntra Bio announces positive data for FG-3246 plus enzalutamide in metastatic castration-resistant prostate cancer.

Vandana Singh

Vir Biotechnology Stock Hits 52-Week High Tuesday - Here's Why

Vir Biotechnology stock skyrockets after $335 million Astellas deal, strong prostate cancer data, and upbeat earnings boost outlook.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

399.70B

Investing Cash Flow (TTM)

-63.89B

Financing Cash Flow (TTM)

-350.90B

Free Cash Flow (TTM)

334.59B

Capital Expenditure (TTM)

-65.11B

Net Change in Cash (TTM)

-15.08B

Valuation Metrics

Enterprise Value

$29.53B

PE Ratio (TTM)

33.81

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.10

PB Ratio (TTM)

2.39

Earnings Yield % (TTM)

2.96%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

13.52

Price / EBITDA (TTM)

12.15

Price / Free Cash Flow (TTM)

12.62

Book Value / Share

$6.19

Company Debt

Total Debt

$740.54B

LT Debt

$320.00B

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$51.54B

Total Cash

$287.05B

Debt to Equity

0.41

Issuance of Debt (TTM)

-$51.54B

Repayment of Debt (TTM)

-$51.54B

Key Statistics

Open

$14.77

Volume / Avg.

0 / 140.87K

Day Range

- - -

52 Wk Range

8.37 - 16.95

Market Cap

$26.46B

P/E Ratio

33.81

Dividend Yield

3.44%

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Astellas Pharma Inc is a specialty international pharmaceutical company. The company focuses on accelerating the discovery, development, and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-tr...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Astellas Pharma (ALPMY) stock?

You can purchase shares of Astellas Pharma (OTCPK:ALPMY) through any online brokerage.

View our list of the best stock brokerages

Who are Astellas Pharma (ALPMY) competitors?

There are no as such competitors for Astellas Pharma.

What is the forecast, or price target, for Astellas Pharma (ALPMY) stock?

There is no analysis for Astellas Pharma to provide a consensus price target.

What is the current price for Astellas Pharma (ALPMY)?

The stock price for Astellas Pharma (OTCPK: ALPMY) is $ last updated .

Does Astellas Pharma (ALPMY) pay a dividend?

There are no upcoming dividends for Astellas Pharma.

When is Astellas Pharma (OTCPK:ALPMY) reporting earnings?

Astellas Pharma does not have any upcoming earnings scheduled.

Is Astellas Pharma (ALPMY) going to split?

There is no upcoming split for Astellas Pharma.

What sector and industry does Astellas Pharma (ALPMY) operate in?

Astellas Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.

Key Statistics

Open

$14.77

Volume / Avg.

0 / 140.87K

Day Range

- - -

52 Wk Range

8.37 - 16.95

Market Cap

$26.46B

P/E Ratio

33.81

Dividend Yield

3.44%

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Astellas Pharma Inc News

These Analysts Boost Their Forecasts On Vir Biotechnology

Avi Kapoor

What's Going On With Kyntra Bio Stock Tuesday?

Kyntra Bio announces positive data for FG-3246 plus enzalutamide in metastatic castration-resistant prostate cancer.

Vandana Singh

Vir Biotechnology Stock Hits 52-Week High Tuesday - Here's Why

Vir Biotechnology stock skyrockets after $335 million Astellas deal, strong prostate cancer data, and upbeat earnings boost outlook.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

399.70B

Investing Cash Flow (TTM)

-63.89B

Financing Cash Flow (TTM)

-350.90B

Free Cash Flow (TTM)

334.59B

Capital Expenditure (TTM)

-65.11B

Net Change in Cash (TTM)

-15.08B

Valuation Metrics

Enterprise Value

$29.53B

PE Ratio (TTM)

33.81

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.10

PB Ratio (TTM)

2.39

Earnings Yield % (TTM)

2.96%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

13.52

Price / EBITDA (TTM)

12.15

Price / Free Cash Flow (TTM)

12.62

Book Value / Share

$6.19

Company Debt

Total Debt

$740.54B

LT Debt

$320.00B

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$51.54B

Total Cash

$287.05B

Debt to Equity

0.41

Issuance of Debt (TTM)

-$51.54B

Repayment of Debt (TTM)

-$51.54B

Key Statistics

Open

$14.77

Volume / Avg.

0 / 140.87K

Day Range

- - -

52 Wk Range

8.37 - 16.95

Market Cap

$26.46B

P/E Ratio

33.81

Dividend Yield

3.44%

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Astellas Pharma (ALPMY) stock?

You can purchase shares of Astellas Pharma (OTCPK:ALPMY) through any online brokerage.

View our list of the best stock brokerages

Who are Astellas Pharma (ALPMY) competitors?

There are no as such competitors for Astellas Pharma.

What is the forecast, or price target, for Astellas Pharma (ALPMY) stock?

There is no analysis for Astellas Pharma to provide a consensus price target.

What is the current price for Astellas Pharma (ALPMY)?

The stock price for Astellas Pharma (OTCPK: ALPMY) is $ last updated .

Does Astellas Pharma (ALPMY) pay a dividend?

There are no upcoming dividends for Astellas Pharma.

When is Astellas Pharma (OTCPK:ALPMY) reporting earnings?

Astellas Pharma does not have any upcoming earnings scheduled.

Is Astellas Pharma (ALPMY) going to split?

There is no upcoming split for Astellas Pharma.

What sector and industry does Astellas Pharma (ALPMY) operate in?

Astellas Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.